Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2004
10/20/2004EP0830136B1 New cryptophycins from synthesis
10/20/2004CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer
10/20/2004CN1171634C Reactor and method for solid phase peptide synthesis
10/19/2004US6806279 For therapy of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, uveitis, and psoriasis, allograft rejection, and graft-versus-host disease
10/19/2004CA2514441A1 Irreversible caspase-3 inhibitors as active site probes
10/14/2004WO2004087767A1 Polypeptide
10/14/2004WO2004087743A2 Anti-hypertensive peptide derivatives and process for preparation thereof
10/14/2004WO2004087742A2 Peptides for reducing symptoms of toxic shock syndrome and septic shck
10/14/2004WO2004087741A1 Crystalline phases of a potent hcv inhibitor
10/14/2004WO2004087740A2 Preserved and stable compositions containing peptide copper complexes and methods related thereto
10/14/2004WO2004087643A1 Deformylase inhibitor, process for preparing the same, and antibacterial composition comprising the same
10/14/2004WO2004078708A3 Novel method for synthesising derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro,-ih-indole-2-carboxylic acid and the use thereof for perindopril synthesis
10/14/2004WO2004032827A3 Hepatitis c virus inhibitors
10/14/2004US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
10/14/2004US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity
10/14/2004US20040204478 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/14/2004US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
10/14/2004US20040204364 Peptides for activation and inhibition of deltaPKC
10/14/2004US20040202761 Cocoa flavor precursor peptides
10/14/2004CA2734606A1 Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
10/14/2004CA2520789A1 Peptides for reducing symptoms of toxic shock syndrome and septic shock
10/13/2004EP1466921A1 Inhibitors of interleukin-1 beta converting enzyme
10/13/2004EP1466917A1 Method for making peptide boronic acids and acids obtainable thereby
10/13/2004EP1466916A1 Peptide boronic acids useful in making salts thereof
10/13/2004EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/13/2004EP1465918A2 Peptides promoting cell adherence, growth and secretion
10/13/2004EP1465917A1 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production
10/13/2004EP1465907A2 Modular peptide-based reagent
10/13/2004EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto
10/13/2004EP1465866A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/13/2004EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase
10/13/2004EP1213284B1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives
10/13/2004EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/13/2004EP1102763B1 Fsh mimetics for the treatment of infertility
10/13/2004EP0839155B1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
10/13/2004EP0736036B1 Kininogen inhibitors
10/13/2004CN1536994A Hypoglycemic agent
10/13/2004CN1535980A New compound with cativity for inhibiting glycine transport factor
10/13/2004CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors
10/13/2004CN1170832C Substituted thiazol [3,2-alphal]azatropylidene derivatives
10/12/2004US6803487 Reacting isobutylene, ethylene and mineral acid;hydrolysis of corresponding ester to alcohol; catalytic dehydrogenation
10/12/2004US6803486 Peptidomimetic; n-aminobutyl-n'-nitroguanidine derivatives
10/12/2004US6803466 Effective against drug-resistant mutants
10/12/2004US6803040 Derivatives of tricyclic antidepressants and protein and polypeptide tricyclic antidepressant derivative conjugates and labels
10/07/2004WO2004086039A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof
10/07/2004WO2004085465A1 Phex substrates and methods using same
10/07/2004WO2004084812A2 Tamandarin analogs and fragments thereof and methods of making and using
10/07/2004WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors
10/07/2004WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists
10/07/2004WO2003059942A3 Peptides and peptidomimetics having anti-proliferative activity and their use
10/07/2004US20040198989 inhibitors of HIV protease for treating AIDS
10/07/2004US20040198988 Novel method for synthesis of (2s, 3as, 7as)-1-{(s)-alanyl}-octahydro-1h-indole-2-carboxylic acid derivatives and use for synthesis of perindopril
10/07/2004US20040198639 Mixture with non-formaldehyde preservative; microbiocides; chemical resistance; drugs, medical equipment, cosmetics; antiaging, wrinkle resistance; skin disorders
10/07/2004US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine.
10/07/2004CA2520662A1 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof
10/07/2004CA2519234A1 Tamandarin analogs and fragments thereof and methods of making and using
10/06/2004EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004EP1463529A2 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy
10/06/2004EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/06/2004EP1085000B1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
10/06/2004CN1535281A Peptides and related molecules that bind to TALL-1
10/06/2004CN1535279A Process for producing dipeptide L-amino acid amide hydrolase to be used therein and process for producing L-amino acid amide hydrolase
10/06/2004CN1535264A Arginine derivatives
10/06/2004CN1169810C Peptide nucleic acid derivatives and preparing process, intermediate for preparing them and medicinal composition containing them
10/06/2004CN1169809C BOC protective beta-tetrahydro carboline carboxylic acid and its nano-preparation, its RGD conjugate, their synthesis and medical application
10/05/2004US6800612 Have vasodilating activity and inhibit the aggregation of the platelets; releasing no
10/05/2004US6800611 Metastin derivatives and their use
10/05/2004US6800287 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
09/2004
09/30/2004WO2004083861A1 Compounds and methods for detecting tripeptidyl protease i
09/30/2004WO2004083258A2 Branched water-soluble polymers and their conjugates
09/30/2004WO2004083238A1 Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
09/30/2004WO2004083237A1 Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and application to the synthesis of perindopril
09/30/2004WO2004083236A2 Cancer treatment using proanp peptides
09/30/2004WO2004082709A1 Angiotensin-converting enzyme inhibitory peptides
09/30/2004WO2004082357A2 Novel method for the synthesis of derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid and application thereof to the synthesis of perindopril
09/30/2004WO2004062568A3 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent
09/30/2004WO2004050689A3 Aza-peptides
09/30/2004WO2004050084A3 Ace-inhibitors having antioxidant and nitricoxid-donor activity
09/30/2004WO2003083055A3 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents
09/30/2004WO2003031574A3 Elastase inhibitors
09/30/2004WO2003026645A8 Tetrapeptide derivative crystals
09/30/2004US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases
09/30/2004US20040192596 Therapeutic fibrin-derived peptides and uses thereof
09/30/2004US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/30/2004US20040191926 Ptp1b inhibitors and ligands
09/30/2004CA2743539A1 Angiotensin-converting enzyme inhibitory peptides
09/30/2004CA2743313A1 Angiotensin-converting enzyme inhibitory peptides
09/30/2004CA2526891A1 Angiotensin-converting enzyme inhibitory peptides
09/30/2004CA2519092A1 Branched water-soluble polymers and their conjugates
09/30/2004CA2518550A1 Cancer treatment using proanp peptides
09/29/2004EP1462455A1 Novel peptides and medicinal uses thereof
09/29/2004EP1461620A2 Flexible method and apparatus for high throughput production and purification of multiple proteins
09/29/2004EP1461069A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia
09/29/2004EP1461001A2 Cancer-associated epitope
09/29/2004EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity
09/29/2004EP1169339B1 Macrocyclic peptides inhibiting the hepatitis c virus ns3 protease
09/29/2004EP1140980B1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same
09/29/2004EP0983095B1 Peptide-coated implants and methods for producing them
09/29/2004EP0627925B1 Trypsin inhibitors